Medpace Holdings, Inc
Case Overview
Status: | Status: Investigating |
Company Name: | Company Name: Medpace Holdings, Inc |
Ticker: | Ticker: MEDP |
Related Attorneys: | Lead Attorneys: Thomas W. Elrod |
Related Practices: | Related Practices: Securities |
The law firm of Kirby McInerney LLP is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP). The investigation concerns whether Medpace and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
On July 22, 2024, Medpace released its second quarter 2024 financial results, significantly missing expectations. In an earnings call the next day, the Company stated that “cancellations were disproportionately high in the month of June” due to “reprioritization, impaired sponsor liquidity, and acquisition of one sponsor by a large pharma with subsequent decision to move the work to an existing preferred provider.” On this news, the price of Medpace shares declined by $79.88, or approximately 18.3%, from $437.18 on July 22, 2024 to close at $357.30 per share on July 23, 2024.
On July 22, 2024, Medpace released its second quarter 2024 financial results, significantly missing expectations. In an earnings call the next day, the Company stated that “cancellations were disproportionately high in the month of June” due to “reprioritization, impaired sponsor liquidity, and acquisition of one sponsor by a large pharma with subsequent decision to move the work to an existing preferred provider.” On this news, the price of Medpace shares declined by $79.88, or approximately 18.3%, from $437.18 on July 22, 2024 to close at $357.30 per share on July 23, 2024.